MediMix Oncology
  • Home
  • Congresses
    • 2025
      • ASCO 2025
      • ASCO GI 2025
      • ENETS 2025
      • ELCC 2025
      • EADO 2025
    • 2024
      • SABCS 2024
      • ESMO 2024
      • ESMO GI 2024
      • ASCO 2024
      • JFHOD 2024
      • ASCO GU 2024
      • ESGO & SGO 2024
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
Browse Tag

in-depth

200 Articles

ICARUS-BREAST01

WonderMedia Team
wondermedia
21 October 2024

Reflections on the rapidly evolving treatment landscape for bladder cancer

WonderMedia Team
wondermedia
21 October 2024

KEYNOTE 006

Admin
Admin
18 October 2024

Expanded analyses from AEGEAN trial

Admin
Admin
18 October 2024

BRAF-mutant metastatic NSCLC

WonderMedia Team
wondermedia
17 October 2024

ICON-9

Admin
Admin
16 October 2024

BREAKWATER: updated results of the safety lead-in

Admin
Admin
16 October 2024

Biomarker analysis of the DAISY trial

Admin
Admin
16 October 2024

ATALANTE/ENGOT-ov29: final overall survival analysis

Admin
Admin
15 October 2024

The CABINET study: cabozantinib for progressive NET

Admin
Admin
10 October 2024
« Previous 1 … 3 4 5 6 7 … 20 Next »

Website created by MediMix © 2025 - Privacy Policy

  • Home
  • Congresses
    • 2025
      • ASCO 2025
      • ASCO GI 2025
      • ENETS 2025
      • ELCC 2025
      • EADO 2025
    • 2024
      • SABCS 2024
      • ESMO 2024
      • ESMO GI 2024
      • ASCO 2024
      • JFHOD 2024
      • ASCO GU 2024
      • ESGO & SGO 2024
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok